Since 2013, the ITOMIC triple negative breast cancer trial has been on the leading edge of where cancer advances are going... equipping physicians and patients with personalized information about how to treat their cancer. To date, 31 patients have been enrolled in the trial, 28 of whom are South Sound CARE patients. The ITOMIC trial has opened up an avenue for this innovative approach for patients with an incurable form of breast cancer. The study is getting international attention in scientific articles... and now in the New York Times.
Related Articles
We’re honored to share that The Rush Companies has been ranked the #2 Best Workplace in Washington State by the Puget Sound Business Journal in the ...
According to the U.S. Chamber of Commerce, we’re currently experiencing a national shortage of 4.5 million homes relative to demand. Other...
The Rush Companies! We’re proud to share that The Rush Companies has been honored with the Puget Sound Business Journal’s 2025 Corporate...